November 2017

Contagion® Peer Exchange panelists discuss the challenge in diagnosing Lyme disease and new technologies that can improve testing.

Although a once-daily pill to prevent HIV exists, US populations at highest risk have the lowest rates of usage.

An examination of broad-spectrum antibiotic use in this patient population is essential for developing strategies to mitigate the risk of these infections.

The growing threat of resistance and substantial costs for treating these infections accentuates the need for programs focused on appropriate treatment.

A short summary of key data and recommendations for 2017-2018.

The constant reassessment of business practices is necessary to ensure that practitioners are not wasting valuable time, resources, and effort on activities that are not producing the desired results.

The virulent pathogen has significant individual and public health implications.

Obesity is found to be a driver of this process.

Despite the availability of highly active agents against HCV, HIV-infected patients require special considerations for drug interactions when considering treatment options.

The fast pace of biotechnology and an increasingly globalized world have changed the face of health security.